We also found that FGF1, a target gene of miR-27b-3p, increases mitochondrial oxidative phosphorylation and that supplementation with recombinant FGF1 attenuates pathological cardiac remodelling caused by TAC and Ang II. This evidence concerns the gene FGF1 and persistent truncus arteriosus.